Market Overview

From Earlier: Illumina Launches Infinium HumanCore Arrays for Economical Large-Scale Genetic Studies

Related ILMN
Heska (HSKA) Jumps: Stock Adds 5.9% in Session - Tale of the Tape
Why AMAG Pharmaceuticals (AMAG) Could Be Positioned for a Slump - Tale of the Tape

Illumina, Inc. (NASDAQ: ILMN) today launched the Infinium HumanCore BeadChip family of products. With content developed in collaboration with several leading research institutions, the customizable Infinium HumanCore and Infinium HumanCoreExome BeadChips support cost-effective, large-scale genotyping and screening studies such as those performed by biobanks, genome centers, and core labs. Based on Illumina's proven Infinium assay, the BeadChips enable genotyping of markers found across diverse populations, making them ideal for researchers engaged in population genetics studies around the world.

Posted-In: News FDA

 

Most Popular

Related Articles (ILMN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters